HC Wainwright Forecasts Lipocine’s Q1 Earnings (NASDAQ:LPCN)
Lipocine Inc. (NASDAQ:LPCN – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2026 EPS estimates for Lipocine in a report released on Tuesday, June 10th. HC Wainwright analyst Y. Chen expects that the specialty pharmaceutical company will post earnings of ($0.47) per share for the quarter. HC Wainwright has a “Buy” […]
Lipocine Inc. (NASDAQ:LPCN – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2026 EPS estimates for Lipocine in a report released on Tuesday, June 10th. HC Wainwright analyst Y. Chen expects that the specialty pharmaceutical company will post earnings of ($0.47) per share for the quarter. HC Wainwright has a “Buy” […]
